• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HZR

HAZER GROUP LIMITED - Charts / Financials

1.27% ! 39.0¢
Market Cap $104.9M  !
Metals & Mining
Add to My Watchlist

Hazer Group Limited is an Australia-based technology company, driving global... Hazer Group Limited is an Australia-based technology company, driving global decarbonization efforts with the commercialization of its disruptive climate-tech. The principal activity of the Company is the research and development of hydrogen and graphitic carbon production technology. The Company’s advanced technology enables the production of clean and economically competitive hydrogen and graphite, using a natural gas (or biogas) feedstock and iron-ore as the process catalyst. The Company has intellectual property rights to a technology (the Hazer Process), which enables the production of hydrogen gas from the thermo-catalytic decomposition of methane (natural gas) with low carbon dioxide emissions and the co-production of a high-purity graphite product. The Company's markets include industrial hydrogen, hydrogen mobility and synthetic graphite. It has facilities, including a research and development lab and a fluid bed reactor pilot plant.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 16.10pm 17/04/2026 (20 minute delay) ?
Day
Open 40.0¢   Day High 43.0¢   Day Low 39.0¢
Daily Volume 99366
Bids   Sellers
Number Price Volume   Number Price Volume
0 38.0¢ 15781   0 39.0¢ 3968

Directors & Senior Management

Mr. Andrew Robert Hinkly Non-Executive Director
Ms. Belinda Wilson Chief People Officer
Ms. Danielle Marguerite Lee Independent Non-Executive Director
Mr. David De Haas Member of Advisory Committee
Mr. Glenn Corrie MD, CEO & Executive Director
Ms. Joan Dabon Company Secretary
Dr. John Andrew Hamilton Independent Non-Executive Director
Mr. Kevin Peakman Member of Advisory Committee
Mr. Luc Kox Chief Commercial Officer
Mr. Neil Brodie Chief Financial Officer
Mr. Tim Forbes Chief Technical Officer
Mr. Timothy Goldsmith Independent Non-Executive Chairman
Mr. Tom Coolican Chief Operations Officer

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
39.0¢ 		Change
-0.005(1.27%) 		Mkt cap ! $104.9M
Open High Low Volume
40.0¢ 43.0¢ 39.0¢ 99.36K

Buyers (Bids)

Vol. Price($)
15781 38.0¢
 

Sellers (Offers)

Price($) Vol.
39.0¢ 3968
Last trade - 16.10pm 17/04/2026 (20 minute delay) ?

Top Stories

Australia metals exploration spend tipped to bounce back this year

According to a new report, global exploration budgets declined for the third consecutive year, although Australia is a bright spot.
Introducing Prairie Lithium: Saskatchewan's permitted lithium project ready to scale We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's bullish note on lithium.
HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre. In this segment, we wrap up the stocks and company announcements you were watching this week on Australia’s #1 finance website. Let’s get straight into it, star...
Ore Resources reports early Phase 4 drilling results pointing to expanding gold system at Forrest prospect Ore Resources (ASX:OR3) is continuing to build momentum at its Coolgardie project in Western Australia, where it’s been rolling out a large-scale Phase 4 drilling program. The company has just released its drilling results from its latest program, and it’s all look...
US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27 AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and founder and managing director Hartley Atkinson believes it’s only going to get better as the growing Oz-based multinational pharmaceutical compan...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.